KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Activity

68 hedge funds and large institutions have $398M invested in KalVista Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 6 closing their positions.

Holders
68
Holders Change
+11
Holders Change %
+19.3%
% of All Funds
1.47%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
17
Increased
20
Reduced
16
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PC
1
Polar Capital
United Kingdom
$32.9M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$21M
3
Millennium Management
3
Millennium Management
New York
$2.76M
4
O
4
OrbiMed
New York
$2.59M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$19M

Top Sellers

1
SHI
1
SV Health Investors
Massachusetts
$52.4M
2
VMI
2
VHCP Management III
New York
$27.8M
3
VMI
3
VHCP Management II
New York
$16.4M
4
BI
4
BVF Inc
California
$0
5
IBT
5
International Biotechnology Trust
United Kingdom
$6.06M
Name Market Value Shares Shares
Change 		Shares
Change %
SHI
1
SV Health Investors
Massachusetts
$52.4M 1,831,548 -716,654 -28%
RCM
2
RA Capital Management
Massachusetts
$41.2M 1,441,070 – –
VC
3
Vivo Capital
California
$38.9M 1,359,149 – –
PC
4
Polar Capital
United Kingdom
$32.9M 1,149,200 +1,070,300 +1,357%
VMI
5
VHCP Management III
New York
$27.8M 970,630 -314,301 -24%
EAM
6
Eventide Asset Management
Massachusetts
$25.8M 900,000 – –
Fidelity Investments
7
Fidelity Investments
Massachusetts
$21M 735,014 +735,014 New
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$19M 665,000 +65,000 +11%
DM
9
Deerfield Management
New York
$18.6M 650,000 – –
VMI
10
VHCP Management II
New York
$16.4M 573,482 -185,699 -24%
GTC
11
Ghost Tree Capital
New York
$11.4M 400,000 -25,000 -6%
IVM
12
InterWest Venture Management
California
$11.1M 388,766 – –
Vanguard Group
13
Vanguard Group
Pennsylvania
$10.2M 357,390 +16,547 +5%
Invesco
14
Invesco
Georgia
$8.98M 313,791 +37,268 +13%
IBT
15
International Biotechnology Trust
United Kingdom
$6.06M 213,061 -106,383 -33%
ACP
16
Acuta Capital Partners
California
$5.88M 205,500 +32,500 +19%
BC
17
Boxer Capital
California
$5.72M 200,000 – –
Renaissance Technologies
18
Renaissance Technologies
New York
$4.58M 159,929 -19,300 -11%
SB
19
Samsara BioCapital
California
$3.39M 118,500 -31,500 -21%
Millennium Management
20
Millennium Management
New York
$2.76M 96,470 +96,470 New
O
21
OrbiMed
New York
$2.59M 90,500 +90,500 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$2.38M 83,095 -786 -0.9%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$2.08M 72,547 +61,414 +552%
FI
24
Fosun International
China
$2.03M 72,606 -64,837 -47%
BlackRock
25
BlackRock
New York
$2.01M 70,257 +25,179 +56%
1
2 3